SJ medical
1 / 5
Pharmacological Action: Dihydroxynaphthylpyridinium chloride is a tetrahydropyrimidine antinematode drug. Its mechanism of action is to produce neuromuscular blocking effects on sensitive nematodes, causing paralysis. It has nicotinic properties, its action is similar to acetylcholine, and it can also inhibit cholinesterase. It is highly effective against Parasitic equine nematodes, common roundworms, equine roundworms, and viviparous nematodes.
Drug Interactions:
(1) Use with methomyl or levamisole may enhance toxicity due to similar mechanisms.
(2) Concurrent use with organophosphates or diethylcarbazine will intensify adverse reactions.
(3) It has an antagonistic effect with piperazine; they should not be used simultaneously.
Dosage and Administration: Oral administration. Single dose per 10kg body weight: Horses 0.25-0.5 tablets; Dogs 0.17-0.33 tablets. Vomiting may occur in small animals as an adverse reaction.
Precautions: Do not use concurrently with muscle relaxants, anticholinesterase drugs, or organophosphate insecticides; use with caution in severely weakened animals.
The company is a high-tech joint-stock enterprise integrating R&D, production, and sales, primarily engaged in the production of veterinary drugs and biological agents, with feed and feed additives as secondary products.
The facility includes a standard production workshop of 900 square meters, a laboratory of 280 square meters, and a GMP-compliant veterinary drug workshop representing a significant investment. Phase I specializes in the production of tablets, granules, disinfectants, and insecticides. Phase II focuses on high-end veterinary products such as oral solutions and terminally sterilized injections.
Possessing an independent R&D center and collaborating with experts from numerous domestic universities, the company maintains a leading technological edge. Striving to become a globally leading supplier, we provide high-quality, safe, and innovative products to customers worldwide.
